Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
Conclusion
The treatment with TMZ is effective and safe in patients with aggressive corticotrophin tumors resistant to conventional therapy. Nevertheless once the disease progresses, a second course of treatment does not seem to be effective.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Brain Tumor | Cancer & Oncology | Carcinoma | Endocrinology | Glioma | Oral Cancer | Pituitary Tumor | Temodar | Thrombocytopenia